Par Drugs And Chemicals Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.076x

Par Drugs And Chemicals Limited cash flow conversion efficiency. Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) has a cash flow conversion efficiency ratio of 0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs80.95 Million ≈ $875.41K USD) by net assets (Rs1.06 Billion ≈ $11.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Par Drugs And Chemicals Limited (2016–2026)

Cash flow conversion efficiency of Par Drugs And Chemicals Limited from 2016 to 2026. This chart illustrates how Par Drugs And Chemicals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Par Drugs And Chemicals Limited for real-time trading data and today's change.

Par Drugs And Chemicals Limited Cash Flow Conversion Ratio Explained

Par Drugs And Chemicals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Par Drugs And Chemicals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Par Drugs And Chemicals Limited ranked by their cash flow conversion efficiency. Also see Par Drugs And Chemicals Limited (PAR) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Tips Films Limited NSE:TIPSFILMS	0.372x
Enry S Island Spa Sb VI:EIOS	N/A
Scienture Holdings, Inc. NASDAQ:SCNX	-0.049x
Pixelplus. Co. Ltd KQ:087600	-0.002x
Ba Ria Thermal Power JSC VN:BTP	-0.010x
Pinnacle Food Group Limited Class A Common Shares NASDAQ:PFAI	N/A
Sab Events & Governance Now Media Limited NSE:SABEVENTS	-0.005x
ZincX Resources Corp V:ZNX	-0.004x

Annual Cash Flow Conversion Efficiency for Par Drugs And Chemicals Limited (2016–2026)

The table below shows the annual cash flow conversion efficiency of Par Drugs And Chemicals Limited from 2016 to 2026. Review cash generation quality of Par Drugs And Chemicals Limited to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs1.12 Billion ≈ $12.11 Million	Rs164.32 Million ≈ $1.78 Million	0.147x	-10.13%
2025-03-31	Rs989.75 Million ≈ $10.70 Million	Rs161.60 Million ≈ $1.75 Million	0.163x	-30.95%
2024-03-31	Rs856.32 Million ≈ $9.26 Million	Rs202.49 Million ≈ $2.19 Million	0.236x	+25.93%
2023-03-31	Rs712.38 Million ≈ $7.70 Million	Rs133.77 Million ≈ $1.45 Million	0.188x	+47.65%
2022-03-31	Rs598.77 Million ≈ $6.48 Million	Rs76.15 Million ≈ $823.55K	0.127x	-45.05%
2021-03-31	Rs522.15 Million ≈ $5.65 Million	Rs120.85 Million ≈ $1.31 Million	0.231x	+22.22%
2020-03-31	Rs406.15 Million ≈ $4.39 Million	Rs76.91 Million ≈ $831.77K	0.189x	-27.23%
2019-03-31	Rs291.17 Million ≈ $3.15 Million	Rs75.77 Million ≈ $819.45K	0.260x	+24.73%
2018-03-31	Rs206.99 Million ≈ $2.24 Million	Rs43.18 Million ≈ $467.01K	0.209x	-56.32%
2017-03-31	Rs192.03 Million ≈ $2.08 Million	Rs91.72 Million ≈ $991.96K	0.478x	+27.00%
2016-03-31	Rs173.56 Million ≈ $1.88 Million	Rs65.27 Million ≈ $705.91K	0.376x	--

About Par Drugs And Chemicals Limited

NSE:PAR India Drug Manufacturers - Specialty & Generic

Market Cap

$15.06 Million

Rs1.39 Billion INR

Market Cap Rank

#25817 Global

#1426 in India

Share Price

Rs113.20

Change (1 day)

+3.91%

52-Week Range

Rs78.58 - Rs168.25

All Time High

Rs348.45